Bartels Wiebke, Adamson Simon, Leung Lisa, Sin Don D, van Eeden Stephan F
Centre for Heart Lung Innovation, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
Int J Chron Obstruct Pulmon Dis. 2018 May 23;13:1647-1654. doi: 10.2147/COPD.S163250. eCollection 2018.
Readmissions are common following acute exacerbations of chronic obstructive pulmonary disease (AECOPD) and are partially responsible for increased morbidity and mortality in COPD. Numerous factors have been shown to predict readmission of patients previously admitted to hospital for AECOPD; however, factors related to readmission in patients who are triaged in emergency departments (EDs) and sent directly home are poorly understood. We postulate that patients seen in the ED for AECOPD and directly sent home have a high readmission rate, and we suspect that inadequate management and follow-up contribute to this high readmission rate.
We conducted a 1-year retrospective study of all patients seen in the ED for AECOPD at an inner-city tertiary care hospital; 30- and 90-day readmission rates for COPD and all-cause admissions to the ED and hospital were determined. Patients discharged directly home from the ED were compared with those admitted to hospital for management. Patient, treatment, and system variables that could potentially impact readmission were documented. Multivariate Poisson regression models were used to determine which factors predicted readmissions.
The readmission rates in the ED group (n=240) were significantly higher than that in the hospitalized group (n=271): 1) the 90-day ED readmissions (1.29 vs 0.51, <0.0001) and 30-day ED readmissions (0.54 vs 0.20, <0.0001) (ED vs hospitalized groups) were significantly higher in the ED group; 2) the time to first readmission was significantly shorter in the ED group than in the hospitalized group (24.1±22 vs 31.8±27.8 days; <0.05). Cardiovascular comorbidities (<0.00001), substance abuse disorder (<0.001), and mental illness (<0.001) were the strongest predictors of readmission in the ED group. Age (<0.01), forced expiratory volume in 1 second (<0.001), and cardiovascular comorbidities (<0.05) were the best predictors for both 30- and 90-day COPD readmission rates in the ED group. Only 50% of the ED group patients received bronchodilators, oral steroids, and antibiotics inclusively, and only 68% were referred for community follow-up. The need for oral steroids to treat AECOPD predicted future 90-day COPD readmissions in the ED group (<0.003).
Patients discharged directly home from EDs have a significantly higher risk of readmission to EDs than those who are hospitalized. One possible reason for this is that COPD management is variable in EDs with <50% receiving appropriate therapy.
慢性阻塞性肺疾病急性加重(AECOPD)后再入院很常见,这在一定程度上导致了慢性阻塞性肺疾病(COPD)发病率和死亡率的增加。已有众多因素被证明可预测既往因AECOPD入院患者的再入院情况;然而,对于在急诊科(ED)接受分诊并直接回家的患者,与再入院相关的因素却知之甚少。我们推测,在ED因AECOPD就诊并直接回家的患者再入院率很高,并且我们怀疑管理和随访不足导致了这种高再入院率。
我们对一家市中心三级护理医院中所有在ED因AECOPD就诊的患者进行了为期1年的回顾性研究;确定了COPD的30天和90天再入院率以及ED和医院的全因入院率。将从ED直接出院回家的患者与入院接受治疗的患者进行比较。记录了可能影响再入院的患者、治疗和系统变量。使用多变量泊松回归模型来确定哪些因素可预测再入院情况。
ED组(n = 240)的再入院率显著高于住院组(n = 271):1)ED组的90天ED再入院率(1.29对0.51,<0.0001)和30天ED再入院率(0.54对0.20,<0.0001)(ED组与住院组相比)显著更高;2)ED组首次再入院的时间显著短于住院组(24.1±22对31.8±27.8天;<0.05)。心血管合并症(<0.00001)、药物滥用障碍(<0.001)和精神疾病(<0.001)是ED组再入院的最强预测因素。年龄(<0.01)、第1秒用力呼气量(<0.001)和心血管合并症(<0.05)是ED组30天和90天COPD再入院率的最佳预测因素。ED组仅50%的患者同时接受了支气管扩张剂、口服类固醇和抗生素治疗,且仅68%的患者被转介进行社区随访。在ED组中,使用口服类固醇治疗AECOPD可预测未来90天的COPD再入院情况(<0.003)。
从ED直接出院回家的患者再入院至ED的风险显著高于住院患者。造成这种情况的一个可能原因是,ED中COPD的管理存在差异,不到50%的患者接受了适当治疗。